Literature DB >> 10886415

Sibling species in the Llutzomyia longipalpis complex differ in levels of mRNA expression for the salivary peptide, maxadilan.

H Yin1, D E Norris, G C Lanzaro.   

Abstract

Maxadilan is a small ( approximately 7 kDa) protein found in the saliva of sand fly species in the Lutzomyia longipalpis complex, vectors of the parasite causing visceral leishmaniasis, Leishmania chagasi. It is a potent vasodilator and also has immunomodulatory affects. Maxadilan recovered from different sibling species of the Lu. longipalpis complex differ in amino acid content by as much as 23%, however all variants possess equivalent vasodilatory activity. Therefore, the dramatic differences in vasodilatory activity of the saliva from different sibling species is probably due to differences in the amounts of maxadilan in their saliva. This is significant because it has been suggested that maxadilan may influence the pathogenesis of leishmanial infections. In this study we measured the amount of maxadilan messenger RNA (mRNA) per pair of salivary glands from individual sand flies by quantitative reverse transcription polymerase chain reaction (RT-PCR) using a competitive method. We report a method using the gene of interest, in this case maxadilan, amplified by the PCR from genomic DNA, as a competitor in the quantitative RT-PCR, taking advantage of differences in the size of these products due to the presence of an intron. Significant differences in amounts of maxadilan mRNA among colonies from Central and South America are described. We found a strong correlation between the amount of maxadilan mRNA detected in salivary glands of different Lu. longipalpis sibling species and previously described differences in the size of erythemas produced by the bite of these species. Therefore, variation in the amount of mRNA suggests that differences in the vasodilatory properties of saliva among the different sibling species are the result of differences in the amount of maxadilan present in the saliva and not differences in the potency of maxadilan peptide variants. The geographical distribution of species with high or low levels of maxadilan gene expression are concordant with the distribution of atypical cutaneous leishmaniasis resulting from infection with Le. chagasi, lending credence to earlier suggestions that maxadilan may be involved with visceralization of this parasite.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886415     DOI: 10.1046/j.1365-2583.2000.00190.x

Source DB:  PubMed          Journal:  Insect Mol Biol        ISSN: 0962-1075            Impact factor:   3.585


  11 in total

1.  Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.

Authors:  P Khare; A K Jaiswal; C D P Tripathi; S Sundar; A Dube
Journal:  Clin Exp Immunol       Date:  2016-04-27       Impact factor: 4.330

2.  Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis.

Authors:  Saeed Ahmed; M Colmenares; L Soong; K Goldsmith-Pestana; L Munstermann; R Molina; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

3.  A new chromosomal phylogeny supports the repeated origin of vectorial capacity in malaria mosquitoes of the Anopheles gambiae complex.

Authors:  Maryam Kamali; Ai Xia; Zhijian Tu; Igor V Sharakhov
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

4.  Leishmaniasis: Middle East and North Africa research and development priorities.

Authors:  Mary Ann McDowell; Sima Rafati; Marcelo Ramalho-Ortigao; Afif Ben Salah
Journal:  PLoS Negl Trop Dis       Date:  2011-07-26

5.  Expression plasticity of Phlebotomus papatasi salivary gland genes in distinct ecotopes through the sand fly season.

Authors:  Iliano V Coutinho-Abreu; Rami Mukbel; Hanafi A Hanafi; Emad Y Fawaz; Shabaan S El-Hossary; Mariha Wadsworth; Gwen Stayback; Dilkushi A Pitts; Mahmoud Abo-Shehada; David F Hoel; Shaden Kamhawi; Marcelo Ramalho-Ortigão; Mary Ann McDowell
Journal:  BMC Ecol       Date:  2011-10-10       Impact factor: 2.964

6.  Phlebotomus papatasi SP15: mRNA expression variability and amino acid sequence polymorphisms of field populations.

Authors:  Marcelo Ramalho-Ortigão; Iliano V Coutinho-Abreu; Valdir Q Balbino; Carlos Alberto S Figueiredo; Rami Mukbel; Hussan Dayem; Hanafi A Hanafi; Shabaan S El-Hossary; Emad El-Din Y Fawaz; Mahmoud Abo-Shehada; David F Hoel; Gwen Stayback; Mariha Wadsworth; Douglas A Shoue; Jenica Abrudan; Neil F Lobo; Andrew R Mahon; Scott J Emrich; Shaden Kamhawi; Frank H Collins; Mary Ann McDowell
Journal:  Parasit Vectors       Date:  2015-05-29       Impact factor: 3.876

Review 7.  The current status of the Lutzomyia longipalpis (Diptera: Psychodidae: Phlebotominae) species complex.

Authors:  Nataly A Souza; Reginaldo P Brazil; Alejandra S Araki
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-03       Impact factor: 2.743

8.  Genetic diversity, phylogeography and molecular clock of the Lutzomyia longipalpis complex (Diptera: Psychodidae).

Authors:  Angélica Pech-May; Janine M Ramsey; Raúl E González Ittig; Magali Giuliani; Pablo Berrozpe; María G Quintana; Oscar D Salomón
Journal:  PLoS Negl Trop Dis       Date:  2018-07-05

9.  Lutzomyia longipalpis s.l. in Brazil and the impact of the Sao Francisco River in the speciation of this sand fly vector.

Authors:  Iliano V Coutinho-Abreu; Ivan V Sonoda; Jose A Fonseca; Marcia A Melo; Valdir Q Balbino; Marcelo Ramalho-Ortigão
Journal:  Parasit Vectors       Date:  2008-06-12       Impact factor: 3.876

10.  Differential expression profiles of the salivary proteins SP15 and SP44 from Phlebotomus papatasi.

Authors:  Nasibeh Hosseini-Vasoukolaei; Farah Idali; Ali Khamesipour; Mohammad Reza Yaghoobi-Ershadi; Shaden Kamhawi; Jesus G Valenzuela; Haleh Edalatkhah; Mohammad Hossein Arandian; Hossein Mirhendi; Shaghayegh Emami; Reza Jafari; Zahra Saeidi; Mahmood Jeddi-Tehrani; Amir Ahmad Akhavan
Journal:  Parasit Vectors       Date:  2016-06-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.